Two biotech powerhouses joined forces in January 2024, when Delaware-based Incyte teamed up with Agilent, a leader in the field of companion diagnostic assays to detect biomarkers of disease, to support the development and commercialization ...
NiKang Therapeutics has signed a new collaboration agreement with the Swiss pharmaceutical giant Roche to study a deadly liver cancer.
WILMINGTON – Seeking to supercharge its cancer drug pipeline, pharmaceutical giant AstraZeneca announced a deal potentially worth more than $1.2 billion to acquire a small California-based biotech firm working on […]
CHRISTIANA – Bank of America announced Wednesday, Nov. 20, that it was donating $500,000 to the Endowed Fund for Translational Cancer Research at ChristianaCare’s Helen F. Graham Cancer Center & […]
John Haydon has put a face on the power of social media and on the willingness of pharmaceutical companies to support patients to deal with the high cost of their […]
Premier Digital Partners
© 2024 Delaware Business Times
